FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2037707055> ?p ?o ?g. }

• W2037707055 endingPage "77" @default.
• W2037707055 startingPage "68" @default.
• W2037707055 abstract "Seventy-seven patients with Raynaud's disease were studied for a mean of 4 years (range 1–11 years) to determine the relationship between autoantibodies and long-term clinical outcome. Anticentromere antibodies (ACA) were assayed by indirect immunofluorescence and by immunoblotting of HeLa cell chromosome extracts. Antibodies to topoisomerase I (anti–topo I) were assayed by immunodiffusion and immunoblotting. Antibodies to the major centromeric protein, CENP-B, and anti–topo I were studied by enzyme-linked immunosorbent assay (ELISA). Eight patients developed telangiectasias, 4 developed skin tightening, and 4 developed a connective tissue disease other than scleroderma. The presence of ACA at the start of the study was associated with the development of telangiectasias (P < 0.003). An initial 100-kd band on immunoblot in conjunction with a positive anti–topo I ELISA result was associated with the development of tight skin (P < 0.0025), while a 100-kd band with a negative anti–topo I ELISA result was associated with the subsequent development of a connective tissue disease other than scleroderma (P < 0.0073). Patients who were initially ACA positive, had the 100-kd band on immunoblot, or had positive ELISA results for anti–topo I or for anti-CENP-B were 63-fold more likely to develop signs of connective tissue disease by the end of the study (P < 0.000009). The presence of any of these autoantibodies was more sensitive (100%), although less specific (75%), than were findings from nailfold capillaroscopy (sensitivity 67% and specificity 95%) in predicting subsequent clinical progression. We conclude that findings of assays for anti–topo I and ACA complement the findings from nailfold capillaroscopy in providing useful prognostic information in Raynaud's disease." @default.
• W2037707055 created "2016-06-24" @default.
• W2037707055 creator A5004056267 @default.
• W2037707055 creator A5034507289 @default.
• W2037707055 creator A5039705109 @default.
• W2037707055 creator A5040902963 @default.
• W2037707055 creator A5047753466 @default.
• W2037707055 creator A5047873642 @default.
• W2037707055 creator A5072564804 @default.
• W2037707055 creator A5085677640 @default.
• W2037707055 creator A5086838203 @default.
• W2037707055 date "1991-01-01" @default.
• W2037707055 modified "2023-10-18" @default.
• W2037707055 title "Prognostic significance of anticentromere antibodies and anti–topoisomerase i antibodies in Raynaud's disease. A prospective study" @default.
• W2037707055 cites W1502969184 @default.
• W2037707055 cites W1507183450 @default.
• W2037707055 cites W1970453525 @default.
• W2037707055 cites W1974283227 @default.
• W2037707055 cites W1976366663 @default.
• W2037707055 cites W1977209683 @default.
• W2037707055 cites W1989678120 @default.
• W2037707055 cites W1996642198 @default.
• W2037707055 cites W1996923159 @default.
• W2037707055 cites W2002027999 @default.
• W2037707055 cites W2028921539 @default.
• W2037707055 cites W2031083024 @default.
• W2037707055 cites W2031403079 @default.
• W2037707055 cites W2036226275 @default.
• W2037707055 cites W2040876249 @default.
• W2037707055 cites W2045114382 @default.
• W2037707055 cites W2047332694 @default.
• W2037707055 cites W2047635939 @default.
• W2037707055 cites W2057391507 @default.
• W2037707055 cites W2064901017 @default.
• W2037707055 cites W2068032875 @default.
• W2037707055 cites W2083033585 @default.
• W2037707055 cites W2143611289 @default.
• W2037707055 cites W2153709755 @default.
• W2037707055 cites W2157578703 @default.
• W2037707055 cites W2165442766 @default.
• W2037707055 cites W2166946653 @default.
• W2037707055 cites W97060029 @default.
• W2037707055 doi "https://doi.org/10.1002/art.1780340111" @default.
• W2037707055 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1845841" @default.
• W2037707055 hasPublicationYear "1991" @default.
• W2037707055 type Work @default.
• W2037707055 sameAs 2037707055 @default.
• W2037707055 citedByCount "140" @default.
• W2037707055 countsByYear W20377070552012 @default.
• W2037707055 countsByYear W20377070552013 @default.
• W2037707055 countsByYear W20377070552014 @default.
• W2037707055 countsByYear W20377070552015 @default.
• W2037707055 countsByYear W20377070552016 @default.
• W2037707055 countsByYear W20377070552017 @default.
• W2037707055 countsByYear W20377070552018 @default.
• W2037707055 countsByYear W20377070552019 @default.
• W2037707055 countsByYear W20377070552021 @default.
• W2037707055 countsByYear W20377070552022 @default.
• W2037707055 countsByYear W20377070552023 @default.
• W2037707055 crossrefType "journal-article" @default.
• W2037707055 hasAuthorship W2037707055A5004056267 @default.
• W2037707055 hasAuthorship W2037707055A5034507289 @default.
• W2037707055 hasAuthorship W2037707055A5039705109 @default.
• W2037707055 hasAuthorship W2037707055A5040902963 @default.
• W2037707055 hasAuthorship W2037707055A5047753466 @default.
• W2037707055 hasAuthorship W2037707055A5047873642 @default.
• W2037707055 hasAuthorship W2037707055A5072564804 @default.
• W2037707055 hasAuthorship W2037707055A5085677640 @default.
• W2037707055 hasAuthorship W2037707055A5086838203 @default.
• W2037707055 hasConcept C142724271 @default.
• W2037707055 hasConcept C159654299 @default.
• W2037707055 hasConcept C163764329 @default.
• W2037707055 hasConcept C180032290 @default.
• W2037707055 hasConcept C203014093 @default.
• W2037707055 hasConcept C2776153627 @default.
• W2037707055 hasConcept C2776670291 @default.
• W2037707055 hasConcept C2778236600 @default.
• W2037707055 hasConcept C2778674544 @default.
• W2037707055 hasConcept C2778962941 @default.
• W2037707055 hasConcept C2779075594 @default.
• W2037707055 hasConcept C2779967694 @default.
• W2037707055 hasConcept C2780648854 @default.
• W2037707055 hasConcept C518705261 @default.
• W2037707055 hasConcept C71924100 @default.
• W2037707055 hasConceptScore W2037707055C142724271 @default.
• W2037707055 hasConceptScore W2037707055C159654299 @default.
• W2037707055 hasConceptScore W2037707055C163764329 @default.
• W2037707055 hasConceptScore W2037707055C180032290 @default.
• W2037707055 hasConceptScore W2037707055C203014093 @default.
• W2037707055 hasConceptScore W2037707055C2776153627 @default.
• W2037707055 hasConceptScore W2037707055C2776670291 @default.
• W2037707055 hasConceptScore W2037707055C2778236600 @default.
• W2037707055 hasConceptScore W2037707055C2778674544 @default.
• W2037707055 hasConceptScore W2037707055C2778962941 @default.
• W2037707055 hasConceptScore W2037707055C2779075594 @default.
• W2037707055 hasConceptScore W2037707055C2779967694 @default.
• W2037707055 hasConceptScore W2037707055C2780648854 @default.
• W2037707055 hasConceptScore W2037707055C518705261 @default.

• next